Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edo Richard

Showing results (21-30 of 199) with videos related to

Pageof 20
Sort By:
The Lancet. Neurology|July 19, 2025
Interpreting the evidence on gantenerumab for dominantly inherited Alzheimer's diseaseSebastian Walsh, Robert Howard, Edo Richard, et al.
BJGP Open|August 21, 2024
Diagnostic information in GP referral letters to a memory clinic: a retrospective cohort studyDemi Ronner, Dorien Oostra, Jurgen Claassen, et al.
AJOB Neuroscience|October 27, 2021
Early Detection of AD Biomarkers and the Ethical Criteria for Screening ProgramsKrista Tromp, Eline Bunnik, Marthe Smedinga, et al.
BMJ (Clinical Research Ed.)|December 19, 2022
Lecanemab for Alzheimer's diseaseSebastian Walsh, Richard Merrick, Edo Richard, et al.
Stroke|January 9, 2010
Vascular care in patients with Alzheimer disease with cerebrovascular lesions slows progression of white matter lesions on MRI: the evaluation of vascular care in Alzheimer's disease (EVA) studyEdo Richard, Alida A Gouw, Philip Scheltens, et al.
BMJ Open|June 25, 2013
MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy studyEdo Richard, Ben A Schmand, Piet Eikelenboom, et al.
Journal of Medical Ethics|August 30, 2018
On the personal utility of Alzheimer's disease-related biomarker testing in the research contextEline M Bunnik, Edo Richard, Richard Milne, et al.
Journal of Bioethical Inquiry|March 20, 2022
Should Doctors Offer Biomarker Testing to Those Afraid to Develop Alzheimer's Dementia? : Applying the Method of Reflective Equilibrium for a Clinical DilemmaMarthe Smedinga, Eline M Bunnik, Edo Richard, et al.
The Gerontologist|November 3, 2020
The Framing of "Alzheimer's Disease": Differences Between Scientific and Lay Literature and Their Ethical ImplicationsMarthe Smedinga, Eline M Bunnik, Edo Richard, et al.
Journal of Bioethical Inquiry|April 4, 2022
Correction to: Should Doctors Offer Biomarker Testing to Those Afraid to Develop Alzheimer's Dementia?Marthe Smedinga, Eline M Bunnik, Edo Richard, et al.
Pageof 20

Showing results (21-30 of 199) with videos related to

Sort By:
Pageof 20
The Lancet. Neurology|July 19, 2025
Interpreting the evidence on gantenerumab for dominantly inherited Alzheimer's diseaseSebastian Walsh, Robert Howard, Edo Richard, et al.
BJGP Open|August 21, 2024
Diagnostic information in GP referral letters to a memory clinic: a retrospective cohort studyDemi Ronner, Dorien Oostra, Jurgen Claassen, et al.
AJOB Neuroscience|October 27, 2021
Early Detection of AD Biomarkers and the Ethical Criteria for Screening ProgramsKrista Tromp, Eline Bunnik, Marthe Smedinga, et al.
BMJ (Clinical Research Ed.)|December 19, 2022
Lecanemab for Alzheimer's diseaseSebastian Walsh, Richard Merrick, Edo Richard, et al.
Stroke|January 9, 2010
Vascular care in patients with Alzheimer disease with cerebrovascular lesions slows progression of white matter lesions on MRI: the evaluation of vascular care in Alzheimer's disease (EVA) studyEdo Richard, Alida A Gouw, Philip Scheltens, et al.
BMJ Open|June 25, 2013
MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy studyEdo Richard, Ben A Schmand, Piet Eikelenboom, et al.
Journal of Medical Ethics|August 30, 2018
On the personal utility of Alzheimer's disease-related biomarker testing in the research contextEline M Bunnik, Edo Richard, Richard Milne, et al.
Journal of Bioethical Inquiry|March 20, 2022
Should Doctors Offer Biomarker Testing to Those Afraid to Develop Alzheimer's Dementia? : Applying the Method of Reflective Equilibrium for a Clinical DilemmaMarthe Smedinga, Eline M Bunnik, Edo Richard, et al.
The Gerontologist|November 3, 2020
The Framing of "Alzheimer's Disease": Differences Between Scientific and Lay Literature and Their Ethical ImplicationsMarthe Smedinga, Eline M Bunnik, Edo Richard, et al.
Journal of Bioethical Inquiry|April 4, 2022
Correction to: Should Doctors Offer Biomarker Testing to Those Afraid to Develop Alzheimer's Dementia?Marthe Smedinga, Eline M Bunnik, Edo Richard, et al.
Pageof 20